Literature DB >> 6440189

Role of training dose in discrimination of nicotine and related compounds by rats.

I P Stolerman, H S Garcha, J A Pratt, R Kumar.   

Abstract

Rats were trained to discriminate nicotine from saline in a two-bar operant conditioning procedure with food reinforcement. There was partial generalization to the nicotine analogues anabasine and cytisine in rats trained to discriminate either 0.2 or 0.4 mg/kg nicotine from saline. However, generalization was complete in rats trained to discriminate 0.1 mg/kg nicotine and, in a novel procedure, any one of three doses of nicotine (0.1, 0.2, or 0.4 mg/kg). There was no generalization to the muscarinic-cholinergic agonist oxotremorine (0.0025-0.04 mg/kg). Additional experiments were carried to further characterize the response of rats trained with nicotine (0.1 mg/kg). These animals failed to generalize to compounds from a range of pharmacological classes (i.e., apomorphine, cocaine, chlordiazepoxide, picrotoxin, and quipazine), but there was partial generalization to amphetamine. Mecamylamine (0.5 mg/kg) but not hexamethonium (5.0 mg/kg) blocked the discrimination of nicotine and the generalization to cytisine. Anabasine (1.0-4.0 mg/kg) did not block the response to nicotine. The results support the view that the nicotine cue is mediated mainly through central cholinergic mechanisms. The dose of nicotine used for training has a very significant influence on the characteristics of the cue and 0.1 mg/kg of nicotine may be more suitable than 0.4 mg/kg as a training dose in future work.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440189     DOI: 10.1007/bf00555223

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

2.  A description of the nicotine stimulus and tests of its generalization to amphetamine.

Authors:  W T Chance; D Murfin; G M Krynock; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

3.  Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain.

Authors:  L G Abood; K Lowy; A Tometsko; H Booth
Journal:  J Neurosci Res       Date:  1978       Impact factor: 4.164

4.  Comparison of pharmacological activity of nicotine and related alkaloids occurring in cigarette smoke.

Authors:  M S Clark; M J Rand; S Vanov
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-08

5.  Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.

Authors:  M J Marks; A C Collins
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

6.  Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms.

Authors:  I P Stolerman; J A Pratt; H S Garcha; V Giardini; R Kumar
Journal:  Neuropharmacology       Date:  1983-09       Impact factor: 5.250

7.  Some studies on cytisine and its methylated derivatives.

Authors:  R B Barlow; L J McLeod
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

8.  OR discrimination: a new drug discrimination method.

Authors:  F C Colpaert; P A Janssen
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432

9.  Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.

Authors:  M A Russell; M Jarvis; R Iyer; C Feyerabend
Journal:  Br Med J       Date:  1980-04-05

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  65 in total

1.  Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist.

Authors:  Mark G LeSage; David Shelley; Marco Pravetoni; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2012-04-04       Impact factor: 3.533

2.  Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats.

Authors:  Andrew C Harris; Irina Stepanov; Paul R Pentel; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-09-30       Impact factor: 4.530

Review 3.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

4.  Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.

Authors:  Janice W Smith; Adrian Mogg; Elisiana Tafi; Eleanor Peacey; Ian A Pullar; Philip Szekeres; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2006-11-18       Impact factor: 4.530

5.  Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.

Authors:  M Jerry Wright; Robert E Vann; Thomas F Gamage; M Imad Damaj; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2006-11-16       Impact factor: 3.533

6.  Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.

Authors:  Mark G LeSage; John R Smethells; Andrew C Harris
Journal:  Behav Anal (Wash D C)       Date:  2018-07-09

7.  Ethanol→Nicotine & Nicotine→Ethanol drug-sequence discriminations: Conditional stimulus control with two interoceptive drug elements in rats.

Authors:  Joseph R Troisi
Journal:  Alcohol       Date:  2018-11-05       Impact factor: 2.405

8.  Acquired appetitive responding to intravenous nicotine reflects a Pavlovian conditioned association.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

9.  Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.

Authors:  Mark G LeSage; David Shelley; Jason T Ross; F Ivy Carroll; William A Corrigall
Journal:  Pharmacol Biochem Behav       Date:  2008-09-09       Impact factor: 3.533

10.  Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Authors:  Robert E Vann; Laura E Wise; Stephen A Varvel; Scott D Philibin; D Matthew Walentiny; Joseph H Porter
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.